A carregar...

Bortezomib in combination with low-dose oral melphalan, dexamethasone and thalidomide for relapsed elderly patients with multiple myeloma

BACKGROUND: The aim of the study was to assess the effects of combination of bortezomib moderate dose and continuous oral low dose melphalan and thalidomide and dexamethasone (BMTD regimen) in elderly patients aged ≥ 65 years with relapsed multiple myeloma (MM). METHODS: Twenty four patients with ad...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Main Authors: Azarm, Taleb, Akbari, Mojtaba, Azarm, Arezo, Mohager, Hamid
Formato: Artigo
Idioma:Inglês
Publicado em: Medknow Publications & Media Pvt Ltd 2012
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC3523442/
https://ncbi.nlm.nih.gov/pubmed/23248651
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!